Rasio rega marang bathi NEXGEL Inc (NXGL)

Localizing capacities in the US eliminates geopolitical risks and trade restrictions for NEXGEL, Inc. (NXGL). Operational efficiency is maintained by outsourcing a portion of production and logistics to external partners. The current P/E ratio is -0.30. The price action of the securities confirms the brand status of a company trusted by medical professionals for its innovative hydrogel systems for tissue regeneration and wound healing.

NEXGEL (NXGL) - Pangali P/E saka 04.07.2022 nganti 12.11.2026

Rincian analitis perusahaan NEXGEL, Inc.

- rega lan prakiraan konsensus rega:

Rega saham nexgel.com|NXGL - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar NEXGEL, Inc.|NXGL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Nilai Akuntansi Saham NEXGEL|NXGL - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku nexgel.com|NXGL - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

- indikator bathi lan kelipatan valuasi:

NXGL - Bathi resik perusahaan|Bathi mangsa ngarep NEXGEL, Inc.|NXGL - Pangali P/E|Rasio prakiraan rega marang bathi NEXGEL Inc.|NXGL - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan NEXGEL, Inc.|NXGL - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan NEXGEL|NXGL - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan nexgel.com|NXGL - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep NEXGEL, Inc.

Analisis umum perusahaan:nexgel.com, NXGL

The P/E ratio determines the cost per unit of profit, allowing an investor to assess the premium paid for an asset and its resilience to market shocks. By analyzing the P/E time series of NEXGEL, Inc. (NXGL), one can compare the market value of NEXGEL, Inc. (NXGL) with predictable revenues from regular medical hydrogel supplies, which helps differentiate a fair business valuation from speculative risk given the high repeatability of sales.

Analisis perusahaan pesaing

Pangali P/E intuitive.com|Rasio rega marang bathi Danaher (DHR)|Rasio rega marang bathi BDX (BD)|STERIS Corporation - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik WST|Baxter International - Pangali P/E|Periode bali modal bisnis masimo.com MASI|Stevanato Group (STVN) - Rasio rega marang bathi|Pangali rega marang bathi TFX|Rasio rega marang bathi Merit Medical Systems Inc|Nobel Biocare (NVST) - Periode bali modal bisnis|Koefisien rega marang bathi ICUI (ICU Medical, Inc.)|Rasio rega pasar marang bathi resik XRAY|Rasio rega marang bathi LeMaitre Vascular LMAT|Nilai perusahaan marang bathi resik ATRC|STAA: Koefisien rega marang bathi|NAGE - Pangali P/E|ZimVie Inc. (ZIMV) - Rasio rega marang bathi|Koefisien rega marang bathi angiodynamics.com|CERS (Cerus) - Pangali P/E|Kapitalisasi marang bathi Alpha Teknova TKNO|Rasio rega marang bathi Monogram Technologies Inc (MGRM)|sharpstechnology.com - Pangali rega marang bathi|InfuSystem Holdings, Inc. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik UTMD (utahmed.com)|KRMD - Rasio rega marang bathi|Periode bali modal bisnis Nyxoah SA NYXH|Microbot Medical Inc (MBOT) - Rasio rega marang bathi|Pangali rega marang bathi PDEX|ZTEK (Zentek Ltd.) - Pangali P/E|Kapitalisasi marang bathi elutia.com ELUT|Koefisien rega marang bathi MLSS (Milestone Scientific Inc.)|retractable.com - Pangali rega marang bathi|Pangali P/E HBIO (Harvard Bioscience)|Rasio kapitalisasi marang bathi resik Femasys Corporation|Meihua Medical - Pangali P/E|Kapitalisasi marang bathi Predictive Oncology|callanjmb.com (CJMB) - Rasio rega marang bathi|ATRI (Atrion Corp.) - Rasio rega marang bathi|Koefisien rega marang bathi NURO